8-Bromo-6-chloroimidazo[1,2-a]pyrazine, 95+%, 500mg

(+/-)-trans-4-(4-Fluorophenyl)pyrrolidine-3-carboxylic acid hydrochloride, 95.0%, 1g

(3-Bromo-2-fluoro-5-methylphenyl)boronic acid, 95.0%, 100g

2-Phenoxypropionic Acid>98.0%(GC)(T)500g

4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)benzonitrile, 95+%, 5g

4-(2H-1,3-benzodioxol-5-yl)-6-(thiophen-2-yl)pyrimidin-2-amine, 95.0%, 10g

ETHYL 5-AMINO-1-(QUINOXALIN-2-YL)-1H-PYRAZOLE-4-CARBOXYLATE, 95.0%, 1g

2-Bromo-3',4'-dichlorobenzophenone, 97.0%, 1g

1-Ethyl-3-methyl-9H-pyrido[3,4-b]indole, 97%, 250mg

1-(cyclohexylmethyl)-1H-pyrazol-3-amine, 95.0%, 2g

(S)-1-Aminopropan-2-ol, 98.0%, 100g

3-(4-Morpholine)propyl bromide Hydrobromide, 95.0%, 1g

tert-butyl N-{2-azaspiro[3.4]octan-6-yl}carbamate, 95.0%, 250mg